Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy
- 14 March 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 15 (8) , 1003-1011
Abstract
The first patients with Coronavirus disease 2019 (COVID-19) emerged at the end of 2019. This novel viral infection demonstrated unique features that include prothrombotic clinical presentations. However, one year after the first occurrence, there remain many unanswered questions. We tried to address some of the important queries in this review. We raised the following critical questions. ‘Why is COVID-19 so hypercoagulable?’, ‘Why are most coagulation test results relatively normal?’, ‘Why is COVID-19-associated coagulopathy more thrombotic than most other infectious diseases?’, ‘Why is arterial thrombus formed frequently?’, ‘Is anticoagulant therapy for COVID-19 effective?’, and ‘Are there racial disparities in thrombosis in COVID-19?’ There are commonalities and differences in the pathogeneses and clinical features between COVID-19 and other infectious diseases. Correct understanding will help discussing appropriate anticoagulation prophylaxis or treatment for thromboembolism.Keywords
Funding Information
- Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology of Japan
This publication has 78 references indexed in Scilit:
- Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdownJournal of Trauma and Acute Care Surgery, 2014
- A Practical Approach to the Use of Low Molecular Weight Heparins in VTE Treatment and Prophylaxis in Children and NewbornsPediatric Hematology and Oncology, 2014
- Influence of Race and Sex on Thrombogenicity in a Large Cohort of Coronary Artery Disease PatientsJournal of the American Heart Association, 2014
- The coagulation system and its function in early immune defenseThrombosis and Haemostasis, 2014
- Pathogenesis of the Viral Hemorrhagic FeversAnnual Review of Pathology: Mechanisms of Disease, 2013
- Evidence of Disseminated Intravascular Coagulation in a Hemorrhagic Fever with Renal Syndrome—Scoring Models and Severe IllnessPLOS ONE, 2011
- Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adultsCritical Care, 2010
- Management and investigation of neonatal thromboembolic events: Genetic and acquired risk factorsThrombosis Research, 2009
- Effects of race and ethnicity on the incidence of venous thromboembolismThrombosis Research, 2009
- Ultrastructural pathology of experimental ebola haemorrhagic fever virus infectionThe Journal of Pathology, 1985